Literature DB >> 8290480

Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices.

S P Duddu1, M Vakilynejad, F Jamali, D J Grant.   

Abstract

Since many chiral pharmaceutical excipients, such as cellulose polymers and cyclodextrins, are used as stationary phases for the separation of enantiomers by high performance liquid chromatography (HPLC), it is hypothesized that one enantiomer of a chiral drug will be released faster than the other from a pharmaceutical formulation containing a racemic drug and a chiral excipient. The mechanism of such an event may arise from preferential intermolecular interaction between the chiral excipient and one of the enantiomers. To test this hypothesis, the release of the enantiomers of propranolol hydrochloride into water from formulations containing the chiral excipients, hydroxypropyl methylcellulose (HPMC) or beta-cyclodextrin, was investigated by stereospecific HPLC analysis of the dissolved concentrations of each of the enantiomers from the formulations. The release of the enantiomers of propranolol hydrochloride from the formulations containing HPMC, although variable, was found to be stereoselective. However, the release of propranolol hydrochloride enantiomers from the beta-cyclodextrin complex was found to be non-stereoselective.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290480     DOI: 10.1023/a:1018937123058

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

Review 1.  Crystallographic consequences of molecular dissymmetry.

Authors:  H G Brittain
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

Review 2.  Enantioselective aspects of drug action and disposition: therapeutic pitfalls.

Authors:  F Jamali; R Mehvar; F M Pasutto
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

3.  The FDA perspective on the development of stereoisomers.

Authors:  W H De Camp
Journal:  Chirality       Date:  1989       Impact factor: 2.437

4.  Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form.

Authors:  M Kurozumi; N Nambu; T Nagai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1975-12       Impact factor: 1.645

5.  Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes.

Authors:  D W Armstrong; T J Ward; R D Armstrong; T E Beesley
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

6.  Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: an overview.

Authors:  D E Drayer
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

7.  Some parameters describing the dissolution rate of salicylic acid at controlled pH.

Authors:  J H Collett; J A Rees; N A Dickinson
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

8.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Analysis of Fickian and non-Fickian drug release from polymers.

Authors:  N A Peppas
Journal:  Pharm Acta Helv       Date:  1985
  9 in total
  4 in total

Review 1.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

Review 2.  Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.

Authors:  R Mehvar; F Jamali
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

Review 3.  Enantiospecific analysis: applications in bioanalysis and metabolism.

Authors:  A J Hutt; M R Hadley; S C Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

4.  Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.

Authors:  Deborah Michel; Waleed Mohammed-Saeid; Heather Getson; Caitlin Roy; Masoomeh Poorghorban; Jackson M Chitanda; Ronald Verrall; Ildiko Badea
Journal:  Int J Nanomedicine       Date:  2016-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.